IRIS Institutional Research Information System - OPENBS Open Archive UniBS

VITA, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.492
AS - Asia 10.635
EU - Europa 8.214
SA - Sud America 2.207
AF - Africa 195
OC - Oceania 47
Continente sconosciuto - Info sul continente non disponibili 36
Totale 41.826
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.132
SG - Singapore 3.885
CN - Cina 3.510
IT - Italia 2.030
UA - Ucraina 2.029
BR - Brasile 1.875
HK - Hong Kong 1.393
DE - Germania 1.032
GB - Regno Unito 531
VN - Vietnam 523
FI - Finlandia 493
RU - Federazione Russa 448
TR - Turchia 440
IE - Irlanda 388
PL - Polonia 388
IN - India 266
FR - Francia 251
CA - Canada 180
SE - Svezia 146
AR - Argentina 122
MX - Messico 119
BD - Bangladesh 116
CZ - Repubblica Ceca 105
ZA - Sudafrica 82
NL - Olanda 79
ID - Indonesia 72
IQ - Iraq 62
JP - Giappone 62
EC - Ecuador 56
ES - Italia 56
BE - Belgio 50
AT - Austria 49
SA - Arabia Saudita 49
AU - Australia 45
CO - Colombia 39
UZ - Uzbekistan 33
PK - Pakistan 32
VE - Venezuela 32
IR - Iran 31
PY - Paraguay 30
EU - Europa 29
LT - Lituania 29
MA - Marocco 24
EG - Egitto 20
CL - Cile 19
KE - Kenya 19
CH - Svizzera 18
IL - Israele 16
PE - Perù 16
JO - Giordania 14
NP - Nepal 14
AE - Emirati Arabi Uniti 13
AZ - Azerbaigian 12
ET - Etiopia 12
PT - Portogallo 12
AL - Albania 11
HU - Ungheria 11
UY - Uruguay 11
JM - Giamaica 10
TN - Tunisia 10
BG - Bulgaria 9
KG - Kirghizistan 9
KR - Corea 9
KZ - Kazakistan 9
GR - Grecia 8
HN - Honduras 8
PA - Panama 8
PH - Filippine 8
RO - Romania 8
AM - Armenia 7
CI - Costa d'Avorio 7
DZ - Algeria 7
LB - Libano 7
MY - Malesia 7
PS - Palestinian Territory 7
BO - Bolivia 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
OM - Oman 6
TT - Trinidad e Tobago 6
A1 - Anonimo 5
MU - Mauritius 5
BB - Barbados 4
BH - Bahrain 4
BY - Bielorussia 4
GT - Guatemala 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
DK - Danimarca 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
MD - Moldavia 3
NO - Norvegia 3
RS - Serbia 3
SI - Slovenia 3
SN - Senegal 3
TW - Taiwan 3
DM - Dominica 2
EE - Estonia 2
Totale 41.795
Salva come PNG Salva come JPEG
Città #
Fairfield 2.179
Singapore 1.975
Woodbridge 1.782
Ashburn 1.638
Jacksonville 1.540
Hong Kong 1.381
Houston 1.319
Chandler 1.119
Seattle 864
Cambridge 856
Ann Arbor 807
Wilmington 785
Beijing 726
Princeton 720
New York 559
Nanjing 514
The Dalles 473
Dublin 385
Warsaw 380
Istanbul 368
Los Angeles 367
Brescia 366
Helsinki 282
Milan 236
Munich 230
Dallas 227
Ho Chi Minh City 189
Nanchang 185
Des Moines 181
Redondo Beach 174
São Paulo 166
Moscow 164
Changsha 159
Dearborn 154
Buffalo 147
Shenyang 138
Lancaster 132
Tianjin 129
Jinan 126
Boardman 125
Hebei 124
Chicago 114
San Diego 111
Rome 100
Shanghai 99
San Francisco 96
Hanoi 93
London 82
Jiaxing 80
Hangzhou 73
Brno 70
Toronto 64
Turku 63
Zhengzhou 61
Romola 60
Brooklyn 57
Mexico City 57
Kunming 54
Rio de Janeiro 54
Santa Clara 53
Belo Horizonte 52
Tokyo 52
Guangzhou 50
San Mateo 49
Montreal 45
Nuremberg 45
Johannesburg 43
Washington 43
Stockholm 41
Denver 39
Jakarta 39
Brussels 37
Orem 37
Atlanta 35
Augusta 34
Frankfurt am Main 34
Lanzhou 34
Ningbo 33
Norwalk 33
Tashkent 32
Boston 31
Haikou 31
Phoenix 31
Verona 31
Orange 30
Taizhou 30
Mumbai 29
Porto Alegre 29
Salt Lake City 29
Brasília 28
Curitiba 28
Leawood 28
Olomouc 28
Turin 28
Council Bluffs 27
Düsseldorf 27
Haiphong 27
Chennai 26
Lappeenranta 26
Amsterdam 25
Totale 27.188
Salva come PNG Salva come JPEG
Nome #
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 467
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 311
The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies 232
Il training cognitivo nei pazienti affetti da schizofrenia 230
Predictors of cognitive improvement and normalization under cognitive remediation in patients with schizophrenia. 226
Italian Study on Depressive Disorders (STudio Italiano MAlattia Depressiva, or STIMA-D): a nationwide snapshot of the status of treatment for major depression. 211
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 204
Cognitive remediation in schizophrenia: current status and future perspectives. 192
Autism spectrum disorder and schizophrenia: Do they overlap? 187
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 186
Correlates of autistic traits among patients with borderline personality disorder 183
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. 179
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 179
Autistic traits in a sample of adult patients with schizophrenia: prevalence and correlates 178
Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care. 177
Effectiveness of different modalities of cognitive remediation on symptomatological, neuropsychological, and functional outcome domains in schizophrenia: A prospective study in a real-world setting 174
Adult Autism Subthreshold Spectrum (AdAS Spectrum): Validation of a questionnaire investigating subthreshold autism spectrum 174
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 174
The patient journey project in Italian mental health services: results from a co-designed survey on clinical interventions and current barriers to improve the care of people living with schizophrenia 170
Combined measure of smooth pursuit eye movements and ventricle-brain ratio in schizophrenic disorders. 169
The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia 169
Does cognitive remediation modify the use of psychiatric services and the patterns of care of patients with schizophrenia? 169
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 169
Cognitive remediation in schizophrenia. 165
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 163
Antipsychotic drugs v. barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysis 163
Psychiatric hospitalization rates in italy before and during covid-19: Did they change? an analysis of register data 163
A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. 161
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 159
Effects of cognitive remediation therapy on neurocognition and negative symptoms in schizophrenia: an Italian naturalistic study 158
X-linked mental retardation with Marfanoid habitus. First report of four italian patients. 158
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome. 156
A roadmap to disentangle the molecular etiology of schizophrenia 154
Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: A prospective controlled study in a real-world setting. 152
Factors Associated With Brain Heterogeneity in Schizophrenia 152
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 151
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 151
Autistic symptoms predict social cognitive performance in patients with schizophrenia 151
Adherence to antipsychotics in schizophrenia. 148
Virological and immunological study of schizophrenic patients in relation to CT scan abnormality. 147
A reconsideration of the relationship between cerebral structural abnormalities and family history of schizophrenia. 146
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. 145
Cognitive remediation in schizophrenia: a controlled study 145
Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice 145
Tools for measuring clinical effectiveness. 144
Brain structural abnormalities at the onset of schizophrenia and bipolar disorder: a meta-analysis of controlled magnetic resonance imaging studies 144
Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. 144
Cognitive remediation in the early course of schizophrenia: a critical review. 143
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 143
A genome-wide search for schizophrenia susceptibility genes. 142
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 141
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 140
Season of birth and cerebral ventricular enlargement in schizophrenia 139
Age of onset in familial schizophrenia. 138
Factors affecting antipsychotic drug discontinuation in the treatment of schizophrenia: Evidence from a naturalistic, retrospective, 18-month follow-up study. 136
HLA-DR antigens in schizophrenia. 136
Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome 135
Brain morphology in schizophrenic disorder: prevalence and correlates of diffuse (cortical and subcortical) brain atrophy. 135
Longitudinal studies of brain morphology and outcome of schizophrenic disorder 135
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 134
Factors related to different reasons for antipsychotic drug discontinuation in the treatment of schizophrenia: A naturalistic 18-month follow-up study. 134
Non pharmacological strategies to enhance adherence and continuity of care in schizophrenia. 134
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 134
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 133
Brain structural effects of antidepressant treatment in major depression 133
Patterns of Structural MRI Abnormalities in Deficit and Nondeficit Schizophrenia. 132
Cognitive remediation in schizophrenia: background, techniques, evidence of efficacy and perspectives 132
Cognitive Remediation Therapy (CRT): presupposti e descrizione. 132
Time course of cerebral ventricular enlargement in schizophrenia supports the hypothesis of its neurodevelopmental nature. 132
Cortical atrophy in schizophrenia: prevalence and associated features 131
The Implementation of Evidence-Based Psychiatric Rehabilitation: Challenges and Opportunities for Mental Health Services 131
Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies 131
Neuropsychological features in patients with severe mental disorders and risk of violence: A prospective multicenter study in Italy 130
COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. 129
CT scan abnormalities and outcome of chronic schizophrenia 129
Disturbi psichici perinatali:focus sulla depressione post partum. 129
Uso della PET e della SPECT in psichiatria 129
Personal resources and depression in schizophrenia: The role of self-esteem, resilience and internalized stigma 129
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 129
Early life events and affective disorder revisited. 128
Hippocampal and amygdala volume reductions in first-episode schizophrenia. 128
Persistence of effectiveness of cognitive remediation interventions in schizophrenia: A 1-year follow-up study. 128
Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies. 127
Fertility and marital status in mood disorders: relationship with age at onset. 127
Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder 127
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 127
Additional Support for Schizophrenia Linkage on Chromosomes 6 and 8: A Multicenter Study 127
Il training cognitivo della Terapia Psicologica Integrata (IPT): presupposti e descrizione. 126
Il rimedio cognitivo nelle psicosi: principi e metodi. 125
Outcome of positive and negative symptoms during neuroleptic therapy in schizophrenia 125
Cerebral ventricular abnormalities in schizophrenia: evidence of their early origin and stability over time. 125
Post-traumatic stress disorder and subthreshold post-traumatic stress disorder in recent male asylum seekers: An expected but overlooked “European” epidemic 125
La cognitività sociale nella schizofrenia: modelli interpretativi e strategie di intervento 124
Male siblings with schizophrenia share alleles at the androgen receptor above chance expectation. 123
A meta-analysis of quantitative magnetic resonance imaging study in first-episode schizophrenia. 123
Qualitative MRI findings in patients with schizophrenia: a controlled study. 122
Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. 122
Structural brain abnormalities in bipolar disorder: what meta-analyses tell us 122
Failure to find a chromosome 18 pericentric linkage in families with schizophrenia 122
Neuromorphological correlates of mood disorders: focus on cerebral ventricular enlargement. 122
Totale 15.290
Salva come PNG Salva come JPEG
Categoria #
all - tutte 213.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.646
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.229 0 0 0 0 0 580 143 534 541 572 604 255
2021/20222.574 185 463 58 150 39 124 123 200 136 284 188 624
2022/20233.141 411 30 31 329 246 798 28 366 550 54 153 145
2023/20243.083 207 90 249 209 167 558 109 84 634 81 58 637
2024/20257.512 93 98 144 820 866 631 594 238 893 711 1.569 855
2025/20268.901 1.445 1.983 1.197 1.999 1.371 906 0 0 0 0 0 0
Totale 42.619